Scottsdale, AZ · Source-checked provider directory

Peptide clinics in Scottsdale, AZ.
Compare providers before you book.

Compare Scottsdale clinics that publicly list peptide therapy, then verify the prescriber, medication status, pharmacy, costs, and follow-up plan before booking. We do not sell peptides or recommend a specific treatment.

Why peptides · why now

Compare Scottsdale providers by verifiable details.

The Phoenix-Scottsdale corridor has been one of the most active anti-aging and longevity medicine markets in the country for nearly two decades. Mayo Clinic Arizona's research presence, the dense concentration of concierge primary-care practices along Camelback and Shea, and a year-round retiree and snowbird population that prioritizes vitality have produced a market that is unusually well-informed about peptide therapy and unusually patient about doing it correctly.

FDA's Pharmacy Compounding Advisory Committee is meeting July 23–24, 2026 to discuss whether BPC-157-, KPV-, TB-500-, and MOTs-C-related bulk drug substances should be included on the 503A Bulks List. The committee provides nonbinding advice; the agenda is not product approval or a blanket authorization for a particular prescription or use. Read the FDA agenda and ask the clinician and pharmacy to explain the current requirements for the exact product under discussion.

For Scottsdale patients, the practical step is to verify the responsible prescriber, exact product, intended use, dispensing pharmacy, evidence, total cost, and follow-up plan before booking.

This directory exists to make those questions easier to ask. We are not affiliated with a clinic, do not sell peptides, and do not recommend a treatment. The national directory is built to help patients compare public information and request a correction when a listing needs one.

Patient questions · Anti-aging and longevity

Understand the exact product before you decide.

Scottsdale peptide searches often center on anti-aging and longevity. The examples below are discussion starters, not treatment recommendations. Regulatory status, evidence, and availability vary by product and intended use; confirm the exact details with a licensed clinician and dispensing pharmacy.

Sermorelin
GHRH analog · GH-axis support
A 29-amino-acid analog of growth-hormone-releasing hormone that stimulates the pituitary's endogenous GH pulse rather than replacing growth hormone directly. Long-established in the clinical literature for somatopause-related decline. The pulsatile mechanism is why most longevity-focused Scottsdale practitioners favor it over exogenous GH.
Sermorelin clinical review: PMC2699646
Tesamorelin
GHRH variant · visceral fat & hepatic
An FDA-approved GHRH analog originally indicated for HIV-associated lipodystrophy. Its published evidence base for visceral adipose reduction and hepatic steatosis is among the strongest of any peptide in clinical use. Scottsdale endocrinology and internal-medicine practices apply it under prescription for metabolic aspects of aging.
Tesamorelin in HIV-associated NAFLD: PMC8366828
GHK-Cu
Copper tripeptide · skin & tissue regen
A naturally occurring tripeptide with a documented role in collagen synthesis, wound healing, and gene-expression modulation associated with tissue regeneration. The Scottsdale aesthetic-medicine and dermatology practices that work with peptides typically prescribe GHK-Cu through their 503A pharmacy partner.
GHK skin regeneration: PMC4508379; GHK-Cu regenerative review: PMC6073405
BPC-157
Cytoprotectant · tissue repair
FDA's July 2026 agenda lists BPC-157-related bulk substances for discussion and identifies ulcerative colitis as the use evaluated in that agenda. A committee discussion does not establish that a product is approved, appropriate, or available for a different purpose. Ask the prescriber what product and use are being discussed and ask the pharmacy how it is sourced.

Before considering any product, ask who is responsible for follow-up, what monitoring is proposed, how questions or adverse effects are handled, and what the complete cost includes. A clinic should explain these details directly rather than relying on a generic protocol.

How to find a clinic in Scottsdale

The questions that actually separate a real clinic from a storefront.

Four questions, asked in this order, will tell you within ten minutes whether a Scottsdale provider is operating under federal compounding law or is something you should walk away from. The market here is sophisticated. The gap between real practices and storefronts is wider, and the answers that distinguish them are clearer.

How will you confirm that sermorelin, tesamorelin, or BPC-157 is appropriate for me before prescribing?
A legitimate Scottsdale practitioner answers with a specific intake protocol: comprehensive metabolic panel, IGF-1, medical history review, and in many cases prior imaging or specialist consult notes. If the answer is "we have a questionnaire" or "fill out the intake online and we'll ship to you," you are not speaking with a clinic. You are speaking with a sales operation.
What is the name of the 503A compounding pharmacy that will prepare my medication?
The answer should be a single named 503A pharmacy, ideally one the prescriber has worked with for years. Phoenix-Scottsdale has several well-established 503A pharmacies serving longevity practices; an experienced clinic will name one without hesitation. A vague answer ("we have several partners," "the pharmacy will reach out to you") indicates the stable compounding relationship federal law requires is not in place. This pattern matches what we document in our Indianapolis, IN directory.
Who oversees my follow-up labs and dose adjustments: you, a nurse, or a third-party telehealth platform?
A peptide-therapy protocol that includes growth-hormone-axis modulators (sermorelin, tesamorelin) requires periodic lab monitoring, typically IGF-1, fasting glucose, and a metabolic panel at six- and twelve-week intervals, then quarterly. If the clinic outsources this to a third-party platform with no physician review, the standard of care is not being met.
What happens to my treatment if the FDA changes Category 2 status mid-protocol?
Ask the clinic to explain the current status of the exact product, what would happen if availability changes, and who will answer that question in writing. The July 23–24, 2026 PCAC meeting is advisory; it does not itself decide whether a particular prescription or use is available.
Verified Scottsdale clinics

Practitioners we've confirmed.

Editorial listing, not an endorsement or paid placement. Service availability can change. Confirm the treating prescriber, current state-license status, medication approval status, dispensing pharmacy, total cost, and follow-up plan directly with the clinic.

Is this your clinic? Activate your listing to add website, phone, and patient actions
Priority Access · Scottsdale, AZ

Get matched as the Scottsdale directory grows.

Join the Scottsdale list

Be first in line for verified Scottsdale peptide clinics.

This patient form is for people seeking care. Clinic applications go through the separate listing form above. No spam. Unsubscribe anytime.

We do not prescribe, dispense, or ship peptides.

Straight Answers · Scottsdale

What you should know before joining the Scottsdale list.

What is FDA reviewing in July 2026?
FDA's Pharmacy Compounding Advisory Committee is meeting July 23–24, 2026 to discuss whether certain BPC-157, KPV, TB-500, and MOTs-C bulk drug substances should be included on the 503A Bulks List. Committee advice is nonbinding and the meeting does not itself authorize a particular product, prescription, or use. Ask a licensed clinician and pharmacy about the current requirements for your situation.
Will Find Peptide Clinics sell me peptides?
No. We do not sell peptides. We maintain a directory of licensed physicians and 503A compounding pharmacies in Scottsdale who may prescribe and prepare them under federal law.
What does a peptide clinic in Scottsdale actually do?
A legitimate peptide clinic in Scottsdale handles four things: a physician-led intake including bloodwork and medical history, a written prescription for a specific compounded formulation, an arrangement with a licensed 503A compounding pharmacy that prepares the medication patient-specific, and ongoing clinical oversight including follow-up labs and titration. Clinics that skip any of these steps, particularly the 503A pharmacy relationship, are not operating within the federal compounding framework. The verification standard we apply mirrors what's documented in our Philadelphia, PA directory and other peer academic-medicine markets.
How do I know a Scottsdale clinic is legitimate?
Three checks. First, confirm the prescribing physician holds an active Arizona medical license. You can search this through the Arizona Medical Board. Second, ask which 503A compounding pharmacy prepares their formulations; the answer should be a specific named pharmacy, not "we have several" or a vague reference. Third, ask how they handle follow-up labs and dose adjustments. Practitioners who treat peptide therapy as a one-time purchase rather than an ongoing clinical relationship are operating outside the standard of care.
Are the peptides themselves FDA-approved?
FDA approval depends on the specific finished drug product and intended use. A committee meeting does not itself authorize a product or use. Ask the clinician to identify the exact product, intended use, approval or compounding status, evidence, and dispensing pharmacy before deciding.
How much does peptide therapy cost in Scottsdale?
Costs in Scottsdale vary by clinic model and compound. Initial physician consultations typically range from $300 to $700, reflecting the concierge-skewed Scottsdale market. Compounded medication costs depend on the specific peptide and protocol length and are billed separately by the 503A pharmacy. Insurance generally does not cover compounded peptide therapy for anti-aging indications. For a fuller cost framework and the questions to ask before committing, see our main FAQ on peptide therapy.
Patient Guides

Check the clinic before you book.

Use these evidence-based checklists to verify the prescriber, exact product, dispensing pharmacy, complete price, follow-up plan, and records.